Latest / Stock Movers / Adobe Falls, Peloton Drops, Hims & Hers Health Mixed As Shares Set for Record Week
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios, Podcasts, radio News, The Stock Movers Report,
- 0:10Speaker 1: your roundup of companies making moves in the stock market,
- 0:13Speaker 1: harnessing the power of Bloomberg Data.
- 0:16Speaker 2: I want to take a look now at some of
- 0:18Speaker 2: the stocks on the move today. I'm Alexis Christophers along
- 0:21Speaker 2: with Isabell Lee Weer in for Paul and Scarlett on
- 0:23Speaker 2: this Friday, and we are joined by Bloomberg's Tatiana Darier
- 0:26Speaker 2: here in studio on a Friday. Tatiana, thanks so much
- 0:29Speaker 2: for stopping in. So we're going to start with the
- 0:31Speaker 2: stock we've been talking about all morning long, and that's Adobe,
- 0:35Speaker 2: one of the losers.
- 0:35Speaker 3: Today, one of the biggest losers today, down seven percent.
- 0:40Speaker 3: They reported largely solid earnings, but the bigger news was
- 0:43Speaker 3: that CEO Narayan will resign from his position as the
- 0:48Speaker 3: street increasingly questions the company's ability to thrive in this
- 0:52Speaker 3: AI era. The CEO has been around for eighteen years
- 0:55Speaker 3: and will remain in the position until the successor has
- 0:58Speaker 3: been appointed. But this comes as a big surprise to
- 1:01Speaker 3: the market, as you guys have mentioned before, with analysts
- 1:05Speaker 3: saying that it adds questions around strategic continuity, capital allocation,
- 1:09Speaker 3: priorities and just the future of the stock. Even though
- 1:12Speaker 3: the business has been growing and steady, there's all these
- 1:16Speaker 3: fears about AI disruptions which have put pressure on the stock. Hence,
- 1:20Speaker 3: perhaps this is not a total surprise, yet the market
- 1:24Speaker 3: always spooked when you get news like that.
- 1:27Speaker 2: What about Peloton, I feel like this is one of
- 1:29Speaker 2: the famous companies during the pandemic and now it's what's
- 1:33Speaker 2: going on?
- 1:34Speaker 3: Yeah, it's lost some of it shines is then as
- 1:37Speaker 3: people have hit the gyms and went back to the office.
- 1:40Speaker 3: But shares are slightly down here as the market rolled
- 1:43Speaker 3: over was hired by two percent earlier and that's on
- 1:46Speaker 3: a story we have on the terminal today. And the
- 1:48Speaker 3: company is working on some new products. They want to
- 1:51Speaker 3: expand their AI drint platform, pushing into strength training insights
- 1:57Speaker 3: and also communicate with users through personally plans. They also
- 2:01Speaker 3: want to prioritize treadmills over bikes and even introduce lower
- 2:05Speaker 3: price versions. And they're pushing for marketing campaigns to appeal
- 2:11Speaker 3: to the growing number of users on GLP one weight
- 2:14Speaker 3: a lot of drugs. And of course this comes after
- 2:16Speaker 3: last year they tried to unsuccessfully revive and update their hardware,
- 2:21Speaker 3: but Wall Street was not impressed about that. Investors punished
- 2:24Speaker 3: the stock. The hope is now that this will go better,
- 2:28Speaker 3: but the caveat these new products are now at least
- 2:32Speaker 3: a year away, is what our reporting shows. So wow,
- 2:35Speaker 3: don't hold your hopes too high.
- 2:37Speaker 2: Just to be patient with the peloton, all right. And
- 2:40Speaker 2: then here's a company we've been talking a lot about.
- 2:42Speaker 2: I was never talking about this company, and now I
- 2:44Speaker 2: feel like I'm doing it, like at least a couple
- 2:46Speaker 2: times a week. Hymn's and Hers.
- 2:47Speaker 3: Health exactly ticker's him AS shares are also slightly down.
- 2:53Speaker 3: It's given back some of its gains, but it has
- 2:56Speaker 3: had a record week, and that's because they just announced
- 2:59Speaker 3: a partnership with Novo Nordisk, So that's behind the fifty
- 3:03Speaker 3: three percent rally this week. As this arrangement will now
- 3:06Speaker 3: allow Hymns to sell Novo's weight loss drugs, not just
- 3:10Speaker 3: the copycats, or not no longer the copycats, rather because
- 3:15Speaker 3: this was a part of the deal, that they will
- 3:16Speaker 3: no longer advertise those compounded versions, but they said they
- 3:20Speaker 3: will still sell them if the doctor requires, and only
- 3:24Speaker 3: say that the deal alleviates near term concerns obviously while
- 3:27Speaker 3: putting Hymns back on the right path. And they're hoping
- 3:31Speaker 3: that this time the agreement will stick because remember from
- 3:34Speaker 3: last year or earlier this year in June, they announced
- 3:37Speaker 3: one and then Nova accused them of deceptive market was
- 3:41Speaker 3: suing them and then resue them in the end. So
- 3:43Speaker 3: all of that has come for now.
- 3:46Speaker 1: The Stock Movers Report from Bloomberg Radio. Check back with
- 3:50Speaker 1: us throughout the day for the latest roundup of companies
- 3:53Speaker 1: making news on Wall Street and for the latest market
- 3:56Speaker 1: moving headlines. Listen to Bloomberg Radio Live, catch us on YouTube,
- 4:00Speaker 1: Bloomberg dot com, and on Applecarplay and Android Auto with
- 4:04Speaker 1: the Bloomberg Business app MHM.